{
    "code": "02023633",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023633",
    "time": "2022-06-17 07:03:23",
    "許可證字號": "衛署藥輸字第023633號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/01\/22",
    "發證日期": "92\/01\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202363307",
    "中文品名": "裴米索注射液３毫克\/毫升",
    "英文品名": "PAMISOL CONCENTRATED INJECTION 3MG\/ML",
    "適應症": "惡性腫瘤之蝕骨性骨頭轉移、惡性高血鈣症。",
    "劑型": "270注射劑",
    "包裝": "5公撮、10公撮小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DISODIUM PAMIDRONATE",
    "限制項目": "02輸　入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0031100  HOSPIRA AUSTRALIA PTY LTD",
            "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200050110",
            "成分名稱": "DISODIUM PAMIDRONATE",
            "含量描述": "",
            "含量": "3.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Pamisol CSP vial-111-04-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023633&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Pamisol LLD MOH 20170524-5-110-04-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023633&Seq=009&Type=9"
        },
        {
            "title": "HSP PAMISOL con Inj 3 mgml LLD MOH 201705244-107-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023633&Seq=008&Type=9"
        },
        {
            "title": "Pamisol CSP carton-111-04-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023633&Seq=005&Type=8"
        },
        {
            "title": "Pamisol carton中文小標籤更新藥商地址-110-04-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023633&Seq=004&Type=8"
        },
        {
            "title": "023633 斐米索注射液(Pamisol Concent.15mg Vial 5ml-瓶身外盒-104-10-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023633&Seq=003&Type=8"
        }
    ]
}